ITGAE and neoplasm: Concomitant flow cytometry and RNA‐seq analyses show elevated CD86 on CD103+ DCs and higher MHC‐I on tumor cells, indicating that TRM reactivation may enhance antigen presentation and broad immune infiltration [127, 128].